Mark James Harris, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1600 Diamond Street, Pharmacy Dept, Onawa, IA 51040 Phone: 712-423-9258 Fax: 712-423-9157 |
Jamie Alan Sorensen Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 821 Iowa Ave, Onawa, IA 51040 Phone: 712-423-1131 |
Dr. Christine Renee Halverson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 903 Iowa Ave, Onawa, IA 51040 Phone: 712-423-1134 |
Aaron Stangel, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 821 Iowa Ave, Onawa, IA 51040 Phone: 712-423-1131 Fax: 712-423-3214 |
Dr. Amy K Brandt, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 903 Iowa Ave, Onawa, IA 51040 Phone: 712-423-1134 |
Mr. William Ray Darrah, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1409 9th St, Onawa, IA 51040 Phone: 712-433-9056 |
News Archive
Impax Laboratories, Inc. today announced that it has settled all pending litigation with Shire LLC and Shire Laboratories, Inc. relating to supply of its authorized generic Adderall XR under the parties' License and Distribution Agreement that was signed in January 2006.
Many expensive programs are exempt from the trigger cuts, including most that are considered "mandatory," which means that some of the largest joint state-federal programs aren't vulnerable. Those include Medicaid, the Children's Health Insurance Program, Temporary Assistance for Needy Families (welfare) and the Supplemental Nutritional Assistance Program.
Mead Johnson Nutrition was notified today by the United States Food & Drug Administration and the Centers for Disease Control that health inspectors have completed their testing on all formula samples collected from the company. These tests confirmed that the Mead Johnson products were safe, and no presence of Cronobacter was detected.
As surgeons balance the need to control their patients' post-surgery pain with the risk that a routine operation could become the gateway to long-term opioid use or addiction, a new study shows the power of an approach that takes a middle way.
Rose Medical Center is the first hospital in Colorado to perform a new and innovative procedure for patients with peripheral arterial disease (PAD). Utilizing the Lutonix 035 Drug Coated Balloon PTA Catheter, surgeons are able to perform a balloon angioplasty in patients with PAD using a special drug-coated balloon (DCB) that delivers a small amount of medication to the inside walls of the diseased portion of the artery.
› Verified 4 days ago